Matthew P. Davidsohn

Author

Also Known As

Alessandro Medda, M. Davidsohn, Matthew Davidsohn, Matthew P Davidsohn, Matthew P. Davidsohn

Publications

234

Citations

H-Index

Concepts

All Affiliations

Matthew P. Davidsohn is an author at Brigham and Women's Hospital specializing in cancer therapeutics, cancer research, and prognostic biomarkers.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	16
2	Medicine	1	1	16
3	Diagnostic Sciences	1	1	16
4	Cancer Therapeutics	1	1	16
5	Clinical Trials	1	1	16

Matthew P. Davidsohn

Publications

198

Citations

H-Index

Page 1

	Year	Citations
Liquid biopsy epigenomic profiling for cancer subtyping Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, Nature Medicine	2023	97
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response Jacob E. Berchuck, Elio Adib, Sarah Abou Alaiwi, Cancer Research	2022	38
Detecting Small Cell Transformation in Patients with Advanced <i>EGFR</i> Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling Talal El Zarif, Catherine B. Meador, Xintao Qiu, Clinical Cancer Research	2024	25
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma Talal El Zarif, Karl Semaan, Marc Eid, Cell Reports	2024	22
Outcomes in patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV) after switch maintenance avelumab (MAv) in the UNITE study. Amanda Nizam, Tanya Jindal, Cindy Jiang, Journal of Clinical Oncology Cancer ManagementClinical EndpointMedian TimePharmacotherapyGynecology Oncology	2024	16

Page 1